Boston, MA -- (SBWIRE) -- 12/26/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Controladora Vuela Co Avcn SA CV (ADR)(NYSE:VLRS), MannKind Corporation(NASDAQ:MNKD), IAMGOLD Corp (USA)(NYSE:IAG), Novavax, Inc.(NASDAQ:NVAX)
Controladora Vuela Co Avcn SA CV (ADR)(NYSE:VLRS) opened its shares at the price of $13.57 for the day. Its closing price was $13.83 after gaining +1.84% for the day. The company traded with the total volume of 4.12 million shares, while its average trading volume remained 385,595.00 shares. Controladora Vuela Compañía de Aviación, S.A.B. de C.V., doing business as Volaris, provides aircraft transportation services.
For How Long VLRS will Fight for Profitability? Read This Trend Analysis report
MannKind Corporation(NASDAQ:MNKD) percentage change surged +2.14% to close at $5.25 with the total traded volume of 3.95 million shares, and average volume of 4.07 million. The 52 week range of the stock remained $2.21 - $8.70, while its day lowest price was $5.15 and it hit its day highest price at $5.33. MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States.
For How Long MNKD’s Gloss will Attract Investors ? Find out via this report
IAMGOLD Corp (USA)(NYSE:IAG) started its trading session with the price of $3.20 and closed at $3.27 by scoring +2.19%. IAG’s stocks traded with total volume of 3.82 million shares, while the average trading volume remained 6.81 million shares. The beta of IAG stands at 0.25. Day range of the stock was $3.20 -$3.30. IAMGOLD Corporation engages in the exploration, development, and operation of mining properties.
Will IAG Continue To Move Higher? Find Out Here
Novavax, Inc.(NASDAQ:NVAX) ended its day with the gain of +0.79% and closed at the price of $5.08 after opening at $5.14. Stock traded during its last trading session with the total volume of 3.61 million shares, as compared to its average volume of 5.66 million shares. Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases.
Why Should Investors Buy NVAX After The Recent Gain? Just Go Here and Find Out
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)